HealthScience
Breakthrough Drug Offers Functional Cure for Hepatitis B
Phase III trials show bepirovirsen achieves functional cure in 19% of chronic hepatitis B patients, marking a major treatment advance.
—5 min read
Tag
2 articles
Phase III trials show bepirovirsen achieves functional cure in 19% of chronic hepatitis B patients, marking a major treatment advance.
Renewed labor tensions at GSK in Belgium as workers denounce reduced severance terms for six employees, calling the situation 'extremely worrying.'